Alzheimer's disease

Citations 411-420 of 570 total displayed.

Past content (since Jan 2001):

VIEWS & REVIEWS
Mild cognitive impairment: Directions for future research

C.A. Luis, D.A. Loewenstein, A. Acevedo, W.W. Barker, and R. Duara
Neurology 2003; 61: 438-444. [Abstract] [Full text] [PDF]  

ARTICLES
Enhanced brain levels of 8,12-iso-iPF₂-VI differentiate AD from frontotemporal dementia

Y. Yao, V. Zhukareva, S. Sung, C.M. Clark, J. Rokach, V.M.-Y. Lee, J.Q. Trojanowski, and D. Praticò
Neurology 2003; 61: 475-478. [Abstract] [Full text] [PDF]  

ARTICLES
Changes in premorbid brain volume predict Alzheimer’s disease pathology

L.C. Silbert, J.F. Quinn, M.M. Moore, E. Corbridge, M.J. Ball, G. Murdoch, G. Sexton, and J.A. Kaye
Neurology 2003; 61: 487-492. [Abstract] [Full text] [PDF]  

ARTICLES
Comparison of memory fMRI response among normal, MCI, and Alzheimer’s patients

M. M. Machulda, H. A. Ward, B. Borowski, J. L. Gunter, R. H. Cha, P. C. O’Brien, R. C. Petersen, B. F. Boeve, D. Knopman, D. F. Tang–Wai, R. J. Ivnik, G. E. Smith, E. G. Tangalos, and C. R. Jack, Jr.
Neurology 2003; 61: 500-506. [Abstract] [Full text] [PDF]  

ARTICLES
Survival in frontotemporal dementia

J.R. Hodges, R. Davies, J. Xuereb, J. Kril, and G. Halliday
Neurology 2003; 61: 349-354. [Abstract] [Full text] [PDF]  

ARTICLES
Different patterns of N-acetylaspartate loss in subcortical ischemic vascular dementia and AD

N. Schuff, A.A. Capizzano, A.T. Du, D.L. Amend, J. O’Neill, D. Norman, W.J. Jagust, H.C. Chui, J.H. Kramer, B.R. Reed, B.L. Miller, K. Yaffe, and M.W. Weiner
Neurology 2003; 61: 358-364. [Abstract] [Full text] [PDF]  

ARTICLES
Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology

M.A. Pappolla, T.K. Bryant-Thomas, D. Herbert, J. Pacheco, M. Fabra Garcia, M. Manjon, X. Girones, T.L. Henry, E. Matsubara, D. Zambon, B. Wolozin, M. Sano, F.F. Cruz-Sanchez, L.J. Thal, S.S. Petanceska, and L.M. Refolo
Neurology 2003; 61: 199-205. [Abstract] [Full text] [PDF]  

ARTICLES
Aß1–42 promotes cholinergic sprouting in patients with AD and Lewy body variant of AD

E. Masliah, M. Alford, A. Adame, E. Rockenstein, D. Galasko, D. Salmon, L. A. Hansen, and L. J. Thal
Neurology 2003; 61: 206-211. [Abstract] [Full text] [PDF]  

BRIEF COMMUNICATIONS
Transthyretin Val122Ile, accumulated Aß, and inclusion-body myositis aspects in cultured muscle

Valerie Askanas, W. King Engel, Janis McFerrin, and Gaetano Vattemi
Neurology 2003; 61: 257-260. [Abstract] [Full text] [PDF]  

EDITORIALS
Setback for an Alzheimer’s disease vaccine: Lessons learned

Paul M. Mathews and Ralph A. Nixon
Neurology 2003; 61: 7-8. [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57